Literature DB >> 18541839

Prospective long-term evaluation of the efficacy, safety, and stability of the phakic intraocular lens for high myopia.

Ruwan A Silva1, Atul Jain, Edward E Manche.   

Abstract

OBJECTIVE: To evaluate the safety, efficacy, predictability, and long-term stability of the Artisan Phakic Intraocular Lens (Ophtec BV, Groningen, the Netherlands) for the correction of high myopia.
METHODS: Prospective analysis of 26 eyes from 15 patients who underwent placement of the Artisan lens for the correction of high and extreme myopia. The mean (SD) preoperative spherical equivalent was - 12.30 (2.69) diopters (D) (range, - 17.25 to - 8.25 D).
RESULTS: At 5 years, the mean (SD) manifest refraction was - 0.37 (0.69) D, with 95% of eyes within 1 D of attempted correction and 74% of eyes within 0.5 D of the attempted correction. Ninety-five percent of eyes achieved an uncorrected visual acuity of 20/40 or better and 74% achieved an uncorrected visual acuity of 20/20 or better. No eyes experienced a loss of 1 or more lines of best-corrected visual acuity. Sixteen percent of eyes gained 2 or more lines of best-corrected visual acuity. From preoperative measurements, the mean endothelial cell density decreased by 14.05% at 5 years postoperatively.
CONCLUSIONS: Placement of the Artisan lens is predictable, stable, and effective at reducing high and extreme myopia 5 years after implantation. The rate of endothelial cell loss was significantly higher than has been reported in previous studies.

Entities:  

Mesh:

Year:  2008        PMID: 18541839     DOI: 10.1001/archopht.126.6.775

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  16 in total

1.  Matched optical quality comparison of 3-year results of PRK-MMC and phakic IOL implantation in the correction of high myopia.

Authors:  M Miraftab; H Hashemi; S Asgari
Journal:  Eye (Lond)       Date:  2015-05-15       Impact factor: 3.775

Review 2.  [Phakic intraocular lenses].

Authors:  T Kohnen; M Shajari
Journal:  Ophthalmologe       Date:  2016-06       Impact factor: 1.059

3.  Visual outcomes after lensectomy and iris claw artisan intraocular lens implantation in patients with Marfan syndrome.

Authors:  Hossein Mohammad Rabie; Parviz Malekifar; Mohammad Ali Javadi; Danial Roshandel; Hamed Esfandiari
Journal:  Int Ophthalmol       Date:  2016-10-05       Impact factor: 2.031

4.  Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®).

Authors:  Virgilio Galvis; John F Villamil; María Fernanda Acuña; Paul A Camacho; Jesús Merayo-Lloves; Alejandro Tello; Sandra Lizeth Zambrano; Juan José Rey; Juan Vicente Espinoza; Angélica María Prada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-28       Impact factor: 3.117

5.  Visual outcomes following Artisan aphakia iris claw lens implantation.

Authors:  K S Lett; P R Chaudhuri
Journal:  Eye (Lond)       Date:  2010-10-15       Impact factor: 3.775

6.  Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-10-01

7.  Artisan iris-fixated toric phakic intraocular lens for the correction of high astigmatism after deep anterior lamellar keratoplasty.

Authors:  Madonna G Al-Dreihi; Bachar I Louka; Anas A Anbari
Journal:  Digit J Ophthalmol       Date:  2013-06-14

8.  Iris Claw versus Scleral Fixation Intraocular Lens Implantation during Pars Plana Vitrectomy.

Authors:  Fereydoun Farrahi; Mostafa Feghhi; Foad Haghi; Ali Kasiri; Abbas Afkari; Mahmood Latifi
Journal:  J Ophthalmic Vis Res       Date:  2012-04

9.  Evaluation of sterile uveitis after iris-fixated phakic intraocular lens implantation.

Authors:  Mohamadreza Sedaghat; Mehran Zarei-Ghanavati; Mohammad-Reza Ansari-Astaneh; Virag Patel; Shameema Sikder
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Apr-Jun

10.  Stability of cachet phakic intraocular lens position during 6-months follow-up.

Authors:  D Schiano Lomoriello; M Lombardo; L Gualdi; L Iacobelli; L Tranchina; P Ducoli; S Serrao
Journal:  Open Ophthalmol J       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.